Good morning :)
MedPlus Health Services Limited

MedPlus Health Services Limited

MEDPLUS Share Price

NSE
₹600.401.39% (-8.45)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max
SIP

With a market cap of ₹7,211 cr, stock is ranked 712

Stock is 2.02x as volatile as Nifty

MEDPLUS Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Avg

Financials growth has been moderate for a few years

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

With a market cap of ₹7,211 cr, stock is ranked 712

Stock is 2.02x as volatile as Nifty

MEDPLUS Performance & Key Metrics

MEDPLUS Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
34.173.65—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
78.695.470.69%

MEDPLUS Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 
100%
Analysts have suggested that investors can buy this stock

from 7 analysts

Price Upside

Earnings Growth

Rev. Growth

See Detailed Forecast

MEDPLUS Company Profile

Medplus Health Services Pvt Ltd is an India-based retail pharmacy company. The Company helps customers to access its products, bills and all health records through online store, medplusmart.com, or on mobile through the MedPlus application.

Investor Presentation

View older View older 

Oct 27, 2026

PDF
View Older Presentations

MEDPLUS Similar Stocks (Peers)

Compare with peers Compare with peers 

MEDPLUS Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
921.28
921.28
1Y Return
19.55%
19.55%
Buy Reco %
90.63
90.63
PE Ratio
166.45
166.45
1Y Return
45.89%
45.89%
Buy Reco %
81.82
81.82
PE Ratio
52.79
52.79
1Y Return
12.82%
12.82%
Buy Reco %
90.91
90.91
PE Ratio
71.78
71.78
1Y Return
42.50%
42.50%
Buy Reco %
68.18
68.18
PE Ratio
-11.42
-11.42
1Y Return
54.11%
54.11%
Buy Reco %
80.00
80.00
Compare with Peers

MEDPLUS Sentiment Analysis

MEDPLUS Sentiment Analysis

New
Crisp summary & key insights to decode earnings calls instantly

MEDPLUS Stock Summary · July 2026

Management framed the quarter as one of rapid network expansion and solid underlying pharmacy-led growth, while also acknowledging margin pressure from rising employee costs and a still-developing franchise model. Q1 FY27 store count reached 5,476 after 146 net additions, with pharmacy revenue up 21.8% year over year and consolidated revenue at INR18,796 million, producing operating EBITDA of INR651 million and a 3.5% margin. Management said pharmacy remains the core driver as the store base scales, and noted that older stores are much more productive, with locations older than 12 months generating 94% of pharmacy sales and a 10.4% store-level EBITDA margin. At the same time, franchise stores made up 131 of the quarter’s 146 net additions, well above earlier expectations, and management described the model as strategically important but still being refined. They also discussed pricing and fee changes to support profitability, while employee expense pressure from wage hikes and new warehouse staffing was expected to weigh more fully in coming quarters. Near term, the company kept its FY27 target of 800 net new stores and said core store and warehousing investment will continue, while discretionary capex remains on hold.

MEDPLUS Stock Growth Drivers
MEDPLUS Stock Growth Drivers
8
  • Store Network Expansion and Franchise-Led Scaling

    MedPlus continues to expand its store base at a strong pace, with 222 gross openings

  • Growing Core Pharmacy Business and Same-Store Momentum

    The core pharmacy business delivered strong operating momentum, with pharmacy revenue up 21.8% year over

MEDPLUS Stock Challenges
MEDPLUS Stock Challenges
8
  • Capex Freeze and Strategic Pause

    The company has put all approved and planned capital expenditure on hold, including projects such

  • Employee Cost Inflation and Margin Pressure

    Operating costs are rising materially because of added warehouse headcount, wage increases in Karnataka and

MEDPLUS Forecast

MEDPLUS Forecasts

Price

Revenue

Earnings

MEDPLUS

MEDPLUS

Income

Balance Sheet

Cash Flow

MEDPLUS Income Statement

MEDPLUS Income Statement

Loading...

Quarterjun 2024sep 2024dec 2024mar 2025jun 2025sep 2025dec 2025mar 2026jun 2026sep 2026
Total Revenue1,497.541,587.771,573.961,525.401,557.651,696.801,824.361,884.981,899.432,057.65
Operating & Other expensessubtract1,395.061,451.731,428.921,373.241,411.901,530.481,647.501,695.211,746.361,867.05
Depreciation/Amortizationsubtract60.0363.1462.4764.2165.6268.5672.7475.9577.9283.83
Interest & Other Itemssubtract24.6625.1225.9726.8427.3728.8230.8333.4833.2736.62
Taxes & Other Itemssubtract3.429.0510.719.7810.4013.4315.4816.368.7014.07
EPS1.203.243.844.323.544.634.825.332.764.73

MEDPLUS Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2027FY 2027

Annual Report Pending

Investor Presentation

Oct 27PDF
Jul 21PDF
Jul 21PDF
FY 2026FY 2026

Annual report

PDF

Investor Presentation

May 20PDF
Jan 30PDF
Oct 31PDF
Aug 2PDF
FY 2025FY 2025

Annual report

PDF

Investor Presentation

May 27PDF
Jan 31PDF
Nov 12PDF
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF
 

MEDPLUS Stock Peers

MEDPLUS Past Performance & Peer Comparison

MEDPLUS Past Performance & Peer Comparison

Comparing 3 stocks from 
Communication ServicesOnline Services

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
MedPlus Health Services Limited32.833.65—
Eternal Limited921.2810.89—
One 97 Communications Ltd166.457.57—
Info Edge (India) Ltd52.791.850.73%
ScreenerCompare valuation on Screener

MEDPLUS Stock Price Comparison

Compare MEDPLUS with any stock or ETF
Compare MEDPLUS with any stock or ETF
MEDPLUS
Loading...

MEDPLUS Holdings

MEDPLUS Shareholdings

MEDPLUS Promoter Holdings Trend

MEDPLUS Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

High Pledged Promoter Holding
Lower pledged promoter holdings is considered better

A significant proportion of promoter holdings is pledged

MEDPLUS Institutional Holdings Trend

MEDPLUS Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Decreased Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has decreased by 1.80%

Tickertape Separator

MEDPLUS Shareholding Pattern

MEDPLUS Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding40.21%27.40%4.51%12.59%15.30%

Dec 2025

Mar 2026

Jun 2026

Sep 2026

MEDPLUS Shareholding History

MEDPLUS Shareholding History

JunSepDec '25MarJunSep16.43%16.54%16.84%15.54%14.39%12.59%

Mutual Funds Invested in MEDPLUS

Mutual Funds Invested in MEDPLUS

No mutual funds holding trends are available

Top 5 Mutual Funds holding MedPlus Health Services Limited




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
4.1758%4.30%0.50%8/45 (+1)
3.0340%1.16%-0.17%35/82 (-6)
2.8359%2.26%-0.43%16/40 (-5)

Compare 3-month MF holding change on Screener

MEDPLUS Insider Trades & Bulk Stock Deals

MEDPLUS Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing MEDPLUS stock

smallcases containing MEDPLUS stock

Looks like this stock is not in any smallcase yet.

MEDPLUS Events

MEDPLUS Events

MEDPLUS Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

MEDPLUS has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

MEDPLUS Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

MEDPLUS has not given any dividends in last 5 years

MEDPLUS Dividends

MEDPLUS Dividends

Hmm, looks like data is unavailable here. Please come back after some time

MEDPLUS Stock News & Opinions

MEDPLUS Stock News & Opinions

Corporate
Corporate
Medplus Health Services repurchased 600,000 equity shares via an open offer on November 18, 2026

Medplus Health Services Limited announced it bought back 6,00,000 equity shares on November 18, 2026, through an open offer pursuant to the Securities and Exchange Board of India (Buyback of Securities) Regulations 2018, according to a filing with the BSE Limited and National Stock Exchange of India Limited.

6 hours agoCapital Market - Live
Corporate
Corporate
Medplus Health Services repurchased 150,000 shares via open offer at Rs 609.4856 per share

Medplus Health Services Limited announced that it bought back 1,50,000 equity shares through an open offer on November 17, 2026, at an average acquisition price of Rs 609.4856 per share, bringing the total number of equity shares bought back to 6,00,000.

1 day agoCapital Market - Live
Corporate
Corporate
Medplus Health Services repurchased 300,000 shares via an open offer, using Nuvama Wealth Management

Medplus Health Services Limited announced it bought back 300,000 equity shares through an open offer on November 16, 2026, utilizing Nuvama Wealth Management Limited as a broker, with an average acquisition price of Rs 618.6321 per share, bringing the total equity shares bought back to 450,000.

2 days agoCapital Market - Live
Corporate
Corporate
Medplus Health Services repurchased 150,000 shares via open offer at Rs 621.44 per share

Medplus Health Services Limited announced it bought back 1,50,000 equity shares on November 13, 2026, through an open offer, according to a regulatory filing with the BSE Limited and National Stock Exchange of India Limited. The average acquisition price was Rs 621.44 per share, excluding transaction costs, with Nuvama Wealth Management Limited acting as the broker.

5 days agoCapital Market - Live
Corporate
Corporate
Medplus Health Services pledged shares to secure NCDs from Agilemed and Lone Furrow Investments

Medplus Health Services Limited has pledged equity shares, primarily to secure Non-Convertible Debentures (NCDs) issued by Agilemed Investments Private Limited and Lone Furrow Investments Private Limited, with promoter Madhukar Reddy Gangadi involved in the transactions. The pledges were largely undertaken to maintain the Security Cover Ratio for existing NCDs, although in some instances, borrowed funds were used to retire previously outstanding NCDs. Lone Furrow Investments Private Limited assumed NCDs previously held by Dureleg Manufacturing Private Limited following an amalgamation. The transactions were primarily intended to support the existing debt obligations of Medplus Health Services and did not represent new borrowing, according to the documentation.

2 weeks agoCapital Market - Live
Corporate
Corporate
Medplus Health shares pledged to secure debt obligations for company and promoter

Medplus Health Services Limited disclosed that shares of the company have been encumbered to secure debt obligations for both the listed company and its promoter, Madhukar Reddy Gangadi. The pledges are primarily linked to the retirement of Non-Convertible Debentures (NCDs) issued by Agilemed Investments Private Limited and Lone Furrow Investments Private Limited, with some additional pledges intended to maintain the Security Cover Ratio for existing debt. As of November 10, 2023, Madhukar Reddy Gangadi pledged 4,500,000 shares, valued at approximately Rs 1.07 billion, while Medplus Health Services Limited pledged 1,800,000 shares, valued at approximately Rs 436.7 million. Catalyst Trustees Limited serves as the security trustee for the NCD holders.

2 weeks agoCapital Market - Live
Corporate
Corporate
Medplus pledged and released shares valued over Rs 139 crore linked to NCDs

Medplus Health Services Limited has engaged in a series of pledge and release transactions involving its equity shares, primarily to secure Non-Convertible Debentures (NCDs) issued by Agilemed Investments Private Limited and Lone Furrow Investments Private Limited. Between December 2023 and February 2024, the company pledged shares valued at a total of over Rs 139 crore, with additional pledges in September and October 2026 totaling 23 lakh shares to maintain Security Cover Ratios. Promoter Madhukar Reddy Gangadi was involved in these transactions, which were partly intended to retire existing NCDs and maintain the SCR without fresh borrowing. Significant share releases occurred on August 21, 2024, valued at approximately Rs 4.39 crore, and December 24, 2025, valued at roughly Rs 3.42 crore, based on closing prices at the time. The transactions are linked to a NCLT-sanctioned amalgamation that transferred NCDs between the two issuing entities.

2 weeks agoCapital Market - Live
Corporate
Corporate
Medplus Health Services' promoter pledged and released shares securing NCDs from Agilemed and Lone Furrow

Medplus Health Services Limited has undergone a series of share pledges and releases primarily to secure Non-Convertible Debentures (NCDs) issued by Agilemed Investments Private Limited and Lone Furrow Investments Private Limited. Promoter Madhukar Reddy Gangadi has been involved in multiple pledge and release transactions, with significant releases occurring in August 2024, valued at approximately Rs 4.39 crore, and December 2025, valued at roughly Rs 3.42 crore. The share pledges, which occurred between December 2023 and October 2026, were often related to maintaining the Security Cover Ratio and did not always involve fresh borrowing. Values of the pledged shares were calculated based on closing prices ranging from Rs 602.95 to Rs 766.05, with subsequent pledges occurring to restore the Security Cover Ratio.

2 weeks agoCapital Market - Live
Corporate
Corporate
MedPlus Health Services to seek board approval for equity share buyback on November 6

MedPlus Health Services Limited will seek board approval on Friday, November 6, 2026, to consider a buyback of its fully paid-up equity shares, in accordance with the Securities and Exchange Board of India (Buy-back of Securities) Regulations, 2018, as amended. Trading window for designated persons will be closed from October 30, 2026, until 48 hours after the board meeting outcome is made public on the company website and the websites of BSE Limited and National Stock Exchange of India Ltd.

2 weeks agoCapital Market - Live
Corporate
Corporate
MedPlus Health Services plans to seek board approval for a share buyback on November 6, 2026

MedPlus Health Services Limited will seek board approval on Friday, November 6, 2026, to consider a proposal for a buyback of its fully paid-up equity shares, in accordance with the Companies Act, 2013, and the Securities and Exchange Board of India (Buy-back of Securities) Regulations, 2018. Trading window for designated persons will be closed from October 30, 2026, until 48 hours after the board meeting outcome is made public on the company website and the websites of BSE Limited and National Stock Exchange of India Ltd.

2 weeks agoCapital Market - Live

Frequently asked questions

  1. The share price of MEDPLUS as on 18th November 2026 is ₹600.40. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. The past returns of MedPlus Health Services Limited (MEDPLUS) share are
    • Past 1 week: -0.43%
    • Past 1 month: -1.10%
    • Past 3 months: -9.69%
    • Past 6 months: -35.30%
    • Past 1 year: -23.74%
    • Past 3 years: -26.64%
    • Past 5 years: -46.45%

  3. The peers or stocks similar to MedPlus Health Services Limited (MEDPLUS) include:

  4. Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of MedPlus Health Services Limited (MEDPLUS) is ₹7211.21 Cr as of 18th November 2026.

  5. The 52-week high of MedPlus Health Services Limited (MEDPLUS) is ₹1022.20 and the 52-week low is ₹565.60.

  6. The P/E (price-to-earnings) ratio of MedPlus Health Services Limited (MEDPLUS) is 32.83. The P/B (price-to-book) ratio is 3.65.

  7. MedPlus Health Services Limited (MEDPLUS) belongs to the Communication Services sector & Online Services sub-sector.

  8. You can directly buy MedPlus Health Services Limited (MEDPLUS) shares on Tickertape. Simply sign up, connect your demat account and place your order.